Mochida Pharmaceutical Co., Ltd. (MFY) Stock Statistics & Valuation Metrics
Total Valuation
Mochida Pharmaceutical Co., Ltd. has a market cap or net worth of EUR 624.96M. The enterprise value is EUR 95.36B.
- Market Cap
- EUR 624.96M
- Enterprise Value
- EUR 95.36B
Share Statistics
Mochida Pharmaceutical Co., Ltd. has 36,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 36,390,000
- Owned by Insiders
- ―
- Owned by Institutions
- 6.13%
Financial Efficiency
Mochida Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.63%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 4.63%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 79.07M
- Profits Per Employee
- 5.34M
- Employee Count
- 1,479
- Asset Turnover
- 0.64
- Inventory Turnover
- 1.68
Valuation Ratios
The current PE Ratio of Mochida Pharmaceutical Co., Ltd. is 13.25. Mochida Pharmaceutical Co., Ltd.’s PEG ratio is 0.25.
- PE Ratio
- 13.25
- PS Ratio
- 1.00
- PB Ratio
- 0.87
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.25
Income Statement
In the last 12 months, Mochida Pharmaceutical Co., Ltd. had revenue of 116.95B and earned 7.90B in profits. Earnings per share was 222.93.
- Revenue
- 116.95B
- Gross Profit
- 56.26B
- Operating Income
- 10.15B
- Pretax Income
- 11.17B
- Net Income
- 7.90B
- EBITDA
- 13.13B
- Earnings Per Share (EPS)
- 222.93
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Mochida Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 2.49%
- Dividend Per Share
- ―
- Dividend Yield
- 2.49%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 7.92%
Stock Price Statistics
- Beta
- 0.46
- 52-Week Price Change
- 7.74%
- 50-Day Moving Average
- 17.51
- 200-Day Moving Average
- 17.77
- Relative Strength Index (RSI)
- 57.18
- Average Volume (3m)
- ―
Important Dates
Mochida Pharmaceutical Co., Ltd. upcoming earnings date is Nov 09, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 03, 2026
- Next Earnings Date
- Nov 09, 2026
- Ex-Dividend Date
- ―
Financial Position
Mochida Pharmaceutical Co., Ltd. as a current ratio of 4.29, with Debt / Equity ratio of 7.13%
- Current Ratio
- 4.29
- Quick Ratio
- 2.99
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- -1.38
- Interest Coverage Ratio
- 140.94
Taxes
In the past 12 months, Mochida Pharmaceutical Co., Ltd. has paid 3.27B in taxes.
- Income Tax
- 3.27B
- Effective Tax Rate
- 0.29
Enterprise Valuation
Mochida Pharmaceutical Co., Ltd. EV to EBITDA ratio is 6.94, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.80
- EV to EBITDA
- 6.94
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Mochida Pharmaceutical Co., Ltd. has EUR 28.41B in cash and marketable securities with EUR 10.81B in debt, giving a net cash position of EUR 17.60B billion.
- Cash & Marketable Securities
- EUR 28.41B
- Total Debt
- EUR 10.81B
- Net Cash
- EUR 17.60B
- Net Cash Per Share
- EUR 483.54
- Tangible Book Value Per Share
- EUR 3,932.67
Margins
Gross margin is 46.97%, with operating margin of 9.13%, and net profit margin of 7.53%.
- Gross Margin
- 46.97%
- Operating Margin
- 9.13%
- Pretax Margin
- 10.86%
- Net Profit Margin
- 7.53%
- EBITDA Margin
- 11.60%
- EBIT Margin
- 9.13%
Analyst Forecast
The average price target for Mochida Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 3.62%
- EPS Growth Forecast
- 37.98%
